Kidney Injury in Newborns with Abdominal Compartment Syndrome

Cover Page


Cite item

Full Text

Abstract

The review represents the problems of a damage to the vital organs in newborns with the Abdominal Compartment Syndrome (ACS). Particular attention is paid to the key predisposing factors and key links of the renal damage’s pathogenesis in newborns with ACS. This review presents the latest data about the role of the hypoxia at the initiation of damage of the renal parenchyma, the prospects for the use of various molecular markers for early diagnostics of nephropathy. Creation of molecular cell test system for the diagnostics and monitoring of renal damage in newborns with ACS is a promising trend in the treatment and prevention nephropathy in newborns.

About the authors

Dmitriy Anatol'evich Morozov

Scientific Centre of Children Health; Sechenov First Moscow State Medical University

Email: damorozov@list.ru
MD, PhD, Professor Russian Federation

Ol'ga Leonidovna Morozova

Sechenov First Moscow State Medical University

Author for correspondence.
Email: morozova_ol@list.ru
MD, PhD, Professor Russian Federation

Aleksey Aleksandrovich Tsyplakov

Saratov State Medical University n. a. V.I. Razumovsky

Email: ambu83@mail.ru
MD, PhD-student Russian Federation

Yuliya Aleksandrovna Mel'nikova

Sechenov First Moscow State Medical University

Email: yumka2007@yandex.ru
student Russian Federation

References

  1. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C, Ivatury R, D’Amours S, Wendon J, Hillman K, Wilmer A. Results from the International сonference of experts on intra-abdominal hypertension and abdominal compartment syndrome. II. Recommendations. Intensive Care Medicine. 2007;33(6):951–962. doi: 10.1007/s00134-007-0592-4
  2. Kirkpatrick AW, Brenneman FD, McLean RF, Rapanos T, Boulanger BR. Is clinical examination an accurate indicator of raised intra-abdominal pressure in critically injured patients? Can J Surg. 2000;43(3):207−211.
  3. Ivatury R, Cheatham M, Malbrain M, Sugrue M. Abdominal Compartment Syndrome. Landes Bioscience, Georgetown. 2006. Р. 295−300.
  4. Арапова АВ, Карцева ЕВ, Кузнецова ЕВ, Бармотин АВ. Применение ксеноперикарда в абдоминальной хирургии у новорожденных. Детская хирургия. 1998;2:13–15. URL: http://www.science-education.ru/ru/article/view?id=22056
  5. Плохих ДА. Результаты исследования физиологических показателей внутрибрюшного давления у новорожденных детей. Мать и дитя в Кузбассе. 2010;2:30−33. URL: http://www.scienceeducation.ru/ru/article/view?id=22056
  6. Грона ВН, Перунский ВП, Весёлый СВ, Споров ГА, Весёлая ВС. Оптимизация лечения врожденных расщелин передней брюшной стенки у детей. Украинский журнал хирургии. 2008;1:105–112.
  7. Меликов АЛ. Коррекция врожденных пороков передней брюшной стенки. Дис. …канд. мед. наук. СПб. 2005. 134 с.
  8. Морозов ДА, Филиппов ЮВ, Городков СЮ, Клюев СА. Синдром интраабдоминальной гипертензии. Вестник хирургии им. И.И. Грекова. 2011;170(1):97–101.
  9. Malbrain MLNG. Abdominal pressure in the critically ill. Curr Opin Crit Care. 2000;6:17−29. URL: http://www.science-education.ru/ru/article/view?id=22056
  10. Туктамышев ВС, Кучумов АГ, Няшин ЮИ, Самарцев ВА, Касатова ЕЮ. Российский журнал биомеханики. 2013;17(1):22−31.
  11. Хрипун АИ, Кузнецов НА, Перевезенцев ИЮ, Сатторов ИА, Махуова ГБ. Синдром интраабдоминальной гипертензии. История и современное состояние вопроса. Бюллетень Восточно-Сибирского научного центра СО РАМН. 2010;3:374–378.
  12. Norton JA, Barie PS, Bollinger RR, Chang AE, Lowry S, Mulvihill SJ, Pass HI, Thompson RW. Surgery: basic science and clinical evidence. New York: Springer. 2008. Р. 2442.
  13. Emerson H. Intra-abdominal pressures. Archives of Internal Medicine. 1911;7(6):754–784. doi: 10.1001/archinte.1911.00060060036002. URL: http://www.mif-ua.com/archive/article/7377
  14. Эсперов БН. Некоторые вопросы внутрибрюшного давления. Труды Куйбышевского медицинского института. 1956;6:239–247. URL: http://www.fesmu.ru/elib/Article.aspx?id=232019
  15. Caldwell CB, Ricotta JJ. Changes in visceral blood flow with elevated intraabdominal pressure. Journal of Surgery Research. 1987;43:14–20. doi: 10.1016/0022-4804(87)90041-2
  16. Cullen DJ, Coyle JP, Teplick R, Long MC. Cardiovascular, pulmonary, and renal effects of massively increased intra-abdominal pressure in critically ill patients. Critical Care Medicine. 1989;17:118–121. doi: 10.1097/00003246-198902000-00002
  17. Kron IL, Harman PK, Nolan SP. The measurement of intra-abdominal pressure as a criterion for abdominal re-exploration. Annals of Surgery. 1984;199(1):28–30. doi: 10.1097/00000658-198401000-00005
  18. Cheatham ML, Safcsak K. Intraabdominal pressure: a revised method for measurement. J Am Coll Surg. 1998;186:594–595. doi: 10.1016/S1072-7515(98)00122-7
  19. Malbrain ML, Chiummello D, Pelosi P. Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: A multiple center epidemiological study. Crit Care Med. 2005;33:315−322.
  20. Deeren D, Dits H, Malbrain MLNG. Correlation between intra-abdominal and intracranial pressure in nontraumatic brain injury. Intensive Care Med. 2005;31:1577−1581.
  21. Goldkrand J, Causey T, Hull E. The changing face of gastroschisis and omphalocele at southeast. Geor J Matern Fetal Neonatal Med. 2004;15:331−335.
  22. Yoshioka H, Aoyama K, Iwamura Y. et al. Two cases of Left-sided gastroschisis: review of the literature. Pediatr Surg Int. 2004;20(6): 472−473.
  23. Olisevich M, Alexander F, Khan M, Cotman K. Gastroschisis revisited: role of intraoperative measurement of abdominal pressure. J Pediatr Surg. 2005;40(5):789−792.
  24. Diaz FJ, Fernandez SA, Gotay F. Identification and management of abdominal compartment syndrome in pediatric intensive care unit. PR Health Sci J. 2006;25:17−22.
  25. Doty JM, Saggi BH, Blocher CR, Fakhry I, Gehr T, Sica D, Sugerman HJ. Effects of increased renal parenchymal pressure on renal function. J Trauma. 2000;48(5):874−877.
  26. Ricci Z, Ronco C. Neonatal RIFLE. Nephrol Dial Transplant. 2013;28(9):2211–2214. doi: 10.1093/ndt/gft074
  27. Абакумов ММ, Смоляр АН. Значение синдрома высокого внутрибрюшного давления в хирургической практике. Хирургия. 2003;12:66–72.
  28. Журавлева ОВ, Золотухина ОА. Мочевыделительная система у детей (анатомо-физиологические особенности). Учебное пособие. Благовещенск. 2010. С. 28.
  29. Kooten C, Daha MR, Van Es LA. Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes. Exp Nephrol. 1999;7(5):429–437. doi: 10.1159/000020622
  30. Bloomfield GL, Ridings PC, Blocher CR. A proposed relationship between increased intra-abdominal, intra-thoracic and intracranial pressure. Crit Care Med. 1997;25(3):496−503.
  31. Kitano Y, Takata M, Sasaki N, Zhang Q, Yamamoto S, Miyasaka K. Influence of increased abdominal pressure on steady-state cardiac performance. J Appl Physiol. 1999;86:1651−1656.
  32. Зорин ИВ. Механизмы прогрессирования нефропатий. Международная школа по детской нефрологии под эгидой International paediatric nephrology assotiation, europen society for paediatric nephrology. Оренбург. 2010. С. 347–257.
  33. Мальцева ЛД. Кислородный режим и функциональная активность тканей организма при патологии мозга и почек в условиях гипероксии. Вестник новых медицинских технологий. 2014;1:3.
  34. Игнатова МС. Прогрессирование нефропатий и возможные пути ренопротекции. Сб. материалов III Российского конгресса «Современные технологии в педиатрии и детской хирургии». М. 2004. C. 213–218.
  35. Глыбочко ПВ, Морозов ДА, Свистунов АА, Морозова ОЛ. Новые возможности диагностики и прогнозирования течения хронического обструктивного пиелонефрита у детей. Цитокины и воспаление. 2009;8(3):64−67.
  36. Menon D, Board PG. A role for glutathione transferase Omega 1 (GSTO1-1) in the glutathionylation cycle. Journal of Biological Chemistry.2013;288(36):25769−25779.
  37. Prowle JR. Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass. Renal Failure. 2015;37(3):408–416. doi: 10.3109/0886022X.2014.1001303
  38. McMahon BA, Koyner JL, Murray PT. Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review. Curr Opin Crit Care. 2010;16(6):550−555.
  39. Scholten BJ. Urinary Alpha and Pi-Glutathione S-transferases in adult patients with type 1 diabetes. Nephron Extra. 2014;4(2):127. doi: 10.1159/000365481
  40. Морозов ДА, Морозова ОЛ, Захарова НБ, Лакомова ДЮ. Ранняя диагностика и прогнозирование течения нефросклероза у детей с пузырно-мочеточниковым рефлюксом. Педиатрическая фармакология. 2012;3(3):112–113.
  41. Charlton JR, Portilla D, Okusa MD. A basic science view of acute kidney injury biomarkers. Nephrol Dial Transplant. 2014;29(7):1301−11.
  42. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009;75:285–294. doi: 10.1038/ki.2008.499
  43. Уразаева ЛИ, Максудова АН. Биомаркеры раннего повреждения почек. Практическая медицина. 2014;4:125−130.
  44. Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E. KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol. 2010;26(4):579−586.
  45. Sun D, Zhao X, Meng L. Relationship between urinary podocytes and kidney diseases. Ren Fail. 2012;34(3):403−407.
  46. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002;61:1475–1485. doi: 10.1046/j.1523-1755.2002.00269.x
  47. Barisoni L, Kriz W, Mundel P, D’Agati V. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999;10:51–61.
  48. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H. Urinary podocytes for the assessment of disease activity in lupus nephritis. Am J Med Sci. 2000;320:112–116. doi: 10.1097/00000441-200008000-00009
  49. Su J, Li SJ, Chen ZH, Zeng CH, Zhou H, Li LS, Liu ZH. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms’ tumor-1 protein used as a podocyte marker. Diabetes Res Clin Pract. 2010;87:167–175. doi: 10.1016/j.diabres.2009.10.022
  50. Song M, Songming H. The signaling pathway of hypoxia inducible factor and its role in renal diseases. J Recept Signal Transduct Res. 2013;33(6):344–348. doi: 10.3109/10799893.2013.830130
  51. Бобкова ИН, Шестакова МВ, Щукина AA. Повреждение подоцитов при сахарном диабете. Сахарный диабет. 2014;17(3):39–50. doi: 10.14341/DM2014339-50
  52. Misra S, Misra KD, Glockner JF. Vascular endothelial growth factor-A, matrix metalloproteinase-1, and macrophage migration inhibition factor changes in the porcine remnant kidney model: Evaluation by MRI. J Vasc Interv Radiol. 2010;21(7):1071–1077. doi: 10.1016/j.jvir.2010.01.047
  53. Gu JW, Manning RD, Young EJ, Shparago M, Sartin B, Bailey AP. Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol. 2009;297(1):142−148.
  54. Wang ZG, Puri TS, Quigg RJ. Characterization of novel VEGF (vascular endothelial growth factor) C splicing isoforms from mouse. Biochem J. 2010;428(3):347−354.
  55. Нанчикеева МЛ. Ранняя стадия поражения почек у больных гипертонической болезнью: клиническое значение, принципы профилактики. Автореф. дис. … докт. мед. наук. М. 2010. 44 с.
  56. Han WK, Bailly V, Abichandani R, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62:237–244. doi: 10.1046/j.1523-1755.2002.00433.x
  57. Nishihara K, Masuda S, Shinke H, Ozawa A, Ichimura T, Yonezawa A, et al. Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity. Biochem Pharmacol. 2013;85(4):570–582. doi: 10.1016/j.bcp.2012.12.019
  58. Böttinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002;13(10):2600−2610.
  59. Viedt C, Orth SR. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant. 2002;12:2043−2047.
  60. Бобкова ИН, Чеботарёва ИВ, Козловская ЛВ, Варшавский ВА, Голицына ЕП. Oпределение экскреции с мочой моноцитарного хемотаксического протеина-1 (MCP-1) и трансформирующего фактора роста-β1 (TGF-β1) — неинвазивный метод оценки тубулоинтерстициального фиброза при хроническом гломерулонефрите. Нефрология. 2006;10(4):49–55.
  61. Bihorac A, Baslanti TO, Cuenca AG, Hobson CE, Ang D, Efron PA, Maier RV, Moore FA, Moldawer LL. Acute kidney injury is associated with early cytokine changes after trauma. The Journal of Trauma and Acute Care Surgery. 2013;74(4):1005. doi: 10.1097/TA.0b013e31828586ec

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies